Cite
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing
MLA
Bhagwan Yadav, et al. Identification of Precision Treatment Strategies for Relapsed/Refractory Multiple Myeloma by Functional Drug Sensitivity Testing. Aug. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fae9b49c2b9b709ccb650583d1ff6e32&authtype=sso&custid=ns315887.
APA
Bhagwan Yadav, Esa Jantunen, Pekka Anttila, Juha Lievonen, Samuli Eldfors, Muntasir Mamun Majumder, Raija Silvennoinen, Caroline A. Heckman, Riikka Karjalainen, Kimmo Porkka, Heikki Kuusanmäki, Alun Parsons, David Tamborero, & Minna Suvela. (2017). Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing.
Chicago
Bhagwan Yadav, Esa Jantunen, Pekka Anttila, Juha Lievonen, Samuli Eldfors, Muntasir Mamun Majumder, Raija Silvennoinen, et al. 2017. “Identification of Precision Treatment Strategies for Relapsed/Refractory Multiple Myeloma by Functional Drug Sensitivity Testing,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fae9b49c2b9b709ccb650583d1ff6e32&authtype=sso&custid=ns315887.